Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal

Core Viewpoint - Vincerx Pharma, Inc. is urging stockholders to vote for the approval of the Dissolution Proposal, which is crucial for potential distributions to stockholders and to minimize ongoing operating costs [1][2][6] Group 1: Dissolution Proposal - The Special Meeting of Stockholders to consider the Dissolution Proposal has been adjourned to August 27, 2025, to allow more time for soliciting votes [1] - Vincerx estimates a potential distribution range of $0.03 to $0.07 per share for stockholders if the Dissolution Proposal is approved [1][6] - Delays in approving the Dissolution Proposal will lead to increased operating costs, further reducing or eliminating funds available for distribution [1][6] Group 2: Importance of Voting - The board of directors unanimously recommends that stockholders vote for the Dissolution Proposal, emphasizing that every vote is significant [2] - Continued delays in the approval process will result in further expenditures, diminishing the likelihood and amounts available for distribution to stockholders [2] Group 3: Voting Process - Stockholders are encouraged to vote quickly and simply, with instructions provided for voting by phone or internet [3][6] - The company has filed a proxy statement with the SEC detailing the reasons for the Dissolution Proposal and its implications for stockholders [4]